Mingyue Optical Lens Co.,Ltd. (SHE:301101)

Market Cap	6.77B -29.0%
Revenue (ttm)	863.61M +11.4%
Net Income	201.92M +11.1%
EPS	1.01 +11.1%
Shares Out	200.73M
PE Ratio	33.55
Forward PE	30.10
Dividend	0.50 (1.47%)
Ex-Dividend Date	May 27, 2026

Volume	2,387,340
Open	33.88
Previous Close	34.04
Day's Range	32.90 - 34.19
52-Week Range	31.71 - 54.12
Beta	0.40
Analysts	Strong Buy
Price Target	48.00 (+42.22%)
Earnings Date	Aug 21, 2026

About Mingyue Optical Lens

Mingyue Optical Lens Co.,Ltd. engages in the research and development, design, and production of lenses, lens raw materials, finished mirrors, frames, and other products in China and internationally. The company offers high refractive index, dual blue light protection, PMC super bright, KR super tough, polarized, intelligent color changing, and progressive multifocus lenses; and customized functional products, such as juvenile myopia management, KR super toughness, smart color change, progressive multifocal, anti-fatigue, high degree of high as...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2002
• Employees: 1,066
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301101

Financial Performance

In 2025, Mingyue Optical Lens's revenue was 827.50 million, an increase of 7.43% compared to the previous year's 770.30 million. Earnings were 192.92 million, an increase of 9.13%.